Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FELRY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,196
Award facts
- Contract value 100% obligated
- $41,196.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $41,196.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on January 13, 2026, with an ultimate completion date of January 14, 2026, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceutical products to Department of Defense healthcare facilities worldwide.
Under the PPV-G GEN V contract framework, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to support recurring medical supply needs of military healthcare operations. The contractor's extensive product portfolio encompasses specialized therapies such as oncology treatments, immunosuppressants, emergency medications, and surgical products, positioning the company as a critical supplier within the federal pharmaceutical supply chain. The underlying IDC, designated as SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with an ultimate completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods.
Quick answers
Who was awarded contract SPE2DU26FELRY?
SPE2DU26FELRY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DU26FELRY worth?
The government has obligated $41,196 on SPE2DU26FELRY.
Is contract SPE2DU26FELRY an order under another contract?
Yes. SPE2DU26FELRY is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELRY competed?
The extent of competition for SPE2DU26FELRY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award